CNP Assurances
ISIN
FR0000120222
Ticker
CNP
Sector
Sub-Industry
Country
France
Year Founded
1959
ISIN
FR0000120222
Ticker
CNP
Sector
Sub-Industry
Country
France
Year Founded
1959
As an insurance, coinsurance and reinsurance provider, CNP Assurances designs innovative personal risk and savings solutions. They are adapted to the different distribution methods of our partners (from the physical network to 100% online) and to the customer needs of each country in which the Group operates.
CNP Assurances specialises in developing its products in close collaboration with each of its partners. In addition to major distribution partnerships in France (with La Banque Postale and Groupe BPCE), in Europe (with Banco Santander) and in Brazil (with Caixa Econômica Federal), each year we sign new agreements.
5,591
Europe + Latin America
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 442,540,100,000.00 | 483,002,400,000.00 | 452,228,200,000.00 |
| Property Plant And Equipment | N/A | 152,300,000.00 | 517,900,000.00 | 448,800,000.00 |
| Investment Property | N/A | 2,411,000,000.00 | 2,722,900,000.00 | 5,609,400,000.00 |
| Goodwill | N/A | 188,900,000.00 | 189,900,000.00 | 237,800,000.00 |
| Other Intangible Assets | N/A | 3,436,400,000.00 | 3,323,400,000.00 | 3,510,000,000.00 |
| Investment Accounted For Using Equity Method | N/A | 526,600,000.00 | 947,700,000.00 | 1,108,100,000.00 |
| Deferred Tax Assets | N/A | 180,200,000.00 | 300,800,000.00 | 1,542,500,000.00 |
| Cash and cash equivalents | N/A | 1,734,000,000.00 | 1,803,300,000.00 | 1,805,600,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | N/A | 0.00 | 0.00 | N/A |
| Equity And Liabilities | N/A | 442,540,100,000.00 | 483,002,400,000.00 | 452,228,200,000.00 |
| Equity | 21,188,000,000.00 | 23,999,300,000.00 | 24,762,900,000.00 | 20,762,300,000.00 |
| Issued Capital | N/A | 686,600,000.00 | 686,600,000.00 | 686,600,000.00 |
| Retained Earnings Profit Loss For Reporting Period | N/A | N/A | 1,552,000,000.00 | 1,939,300,000.00 |
| Additional Paidin Capital | N/A | 1,736,300,000.00 | 1,736,300,000.00 | 1,736,300,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 20,680,200,000.00 | 21,134,200,000.00 | 17,120,300,000.00 |
| Noncontrolling Interests | N/A | 3,319,200,000.00 | 3,628,700,000.00 | 3,642,000,000.00 |
| Deferred Tax Liabilities | N/A | 983,000,000.00 | 847,600,000.00 | 173,300,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 0.00 | 0.00 | N/A |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Other Revenue | 121,800,000.00 | 103,800,000.00 | 94,500,000.00 |
| Other Income | N/A | 0.00 | 100,000.00 |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 5,600,000.00 | -101,200,000.00 | N/A |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 5,600,000.00 | -101,200,000.00 | N/A |
| Income Expenses From Reinsurance Contracts Held Other Than Finance Income Expenses | 141,500,000.00 | 130,800,000.00 | 63,300,000.00 |
| Profit Loss From Operating Activities | 2,506,600,000.00 | 2,596,400,000.00 | 3,070,400,000.00 |
| Finance Costs | 251,700,000.00 | 226,800,000.00 | 193,400,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | 51,800,000.00 | 88,400,000.00 | 114,200,000.00 |
| Income Tax Expense Continuing Operations | 688,900,000.00 | 681,500,000.00 | 752,500,000.00 |
| Profit Loss From Discontinued Operations | 0.00 | 0.00 | N/A |
| Profit (loss) | 1,617,900,000.00 | 1,776,400,000.00 | 2,261,600,000.00 |
| Profit Loss Attributable To Owners Of Parent | 1,350,000,000.00 | 1,552,000,000.00 | 1,939,300,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | -267,900,000.00 | 224,400,000.00 | 322,300,000.00 |
| Line item in (eur) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | 1,617,900,000.00 | 1,776,400,000.00 | 2,261,600,000.00 |
| Adjustments For Reconcile Profit Loss | 2,057,800,000.00 | 3,218,400,000.00 | 3,945,100,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 212,400,000.00 | 314,500,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 24,900,000.00 | -99,300,000.00 | 117,500,000.00 |
| Adjustments For Provisions | 5,400,000.00 | 3,600,000.00 | -45,200,000.00 |
| Adjustments For Fair Value Gains Losses | -1,587,500,000.00 | -5,893,000,000.00 | 3,896,600,000.00 |
| Other Adjustments For Noncash Items | 295,700,000.00 | 575,900,000.00 | -161,000,000.00 |
| Adjustments For Reconcile Profit Loss | 2,057,800,000.00 | 3,218,400,000.00 | 3,945,100,000.00 |
| Dividends Received Classified As Operating Activities | 40,400,000.00 | 47,200,000.00 | 82,900,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | 880,800,000.00 | 473,100,000.00 | 799,600,000.00 |
| Cash Flows From Used In Operating Activities | 5,775,500,000.00 | 9,331,400,000.00 | 6,598,800,000.00 |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | 0.00 | 0.00 | -16,600,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | -12,500,000.00 | 98,100,000.00 | 1,016,900,000.00 |
| Cash Flows From Used In Investing Activities | -5,361,000,000.00 | -2,380,300,000.00 | -13,039,700,000.00 |
| Proceeds From Issuing Shares | 0.00 | 0.00 | 5,500,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | 0.00 | 431,500,000.00 |
| Payments Of Other Equity Instruments | 0.00 | 0.00 | N/A |
| Proceeds From Borrowings Classified As Financing Activities | 1,250,000,000.00 | 1,094,200,000.00 | 575,100,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 754,800,000.00 | 1,039,600,000.00 | 1,000,000,000.00 |
| Dividends Paid Classified As Financing Activities | 571,100,000.00 | 1,314,300,000.00 | 913,700,000.00 |
| Interest Paid Classified As Financing Activities | 313,200,000.00 | 288,700,000.00 | 258,800,000.00 |
| Cash Flows From Used In Financing Activities | -389,400,000.00 | -1,546,000,000.00 | -2,023,400,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -24,800,000.00 | 8,500,000.00 | -22,600,000.00 |
| Cash and cash equivalents | 1,734,000,000.00 | 1,803,300,000.00 | 1,805,600,000.00 |
Please note that some sums might not add up.
FR0000120222
969500QKVPV2H8UXM738
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.